References
- Gatti RA, Boder E, Vinters HV, et al. Ataxia-telangiectasia: an interdisciplinary approach to pathogenesis. Medicine (Baltimore). 1991;70(2):99–117.
- Sandoval N, Platzer M, Rosenthal A, et al. Characterization of ATM gene mutations in 66 ataxia telangiectasia families. Hum Mol Genet. 1999;8(1):69–79.
- Podralska MJ, Stembalska A, Ślęzak R, et al. Ten new ATM alterations in Polish patients with ataxia-telangiectasia. Mol Genet Genomic Med. 2014;2(6):504–511.
- Leuzzi V, Micheli R, D’Agnano D, et al. Positive effect of erythrocyte-delivered dexamethasone in ataxia-telangiectasia. Neurol Neuroimmunol Neuroinflammation. 2015;2:98.
- Ambrose M, Goldstine JV, Gatti RA. Intrinsic mitochondrial dysfunction in ATM-deficient lymphoblastoid cells. Hum Mol Genet. 2007;16(18):2154–2164.
- Gatti RA, Berkel I, Boder E, et al. Localization of an ataxia-telangiectasia gene to chromosome 11q22-23. Nature. 1988;336(6199):577–580.
- Huang Y, Yang L, Wang J, et al. Twelve novel ATM mutations identified in Chinese Ataxia Telangiectasia patients. Neuromolecular Med. 2013;15(3):536–540.
- Collins FS, Varmus H. A new initiative on precision medicine. N Engl J Med. 2015;372(9):793–795.
- Kozlov SV, Graham ME, Jakob B, et al. Autophosphorylation and ATM activation: additional sites add to the complexity. J Biol Chem. 2011; 286(11):9107–9119.
- Wang Q, Lu Q, Zhao H. A review of study designs and statistical methods for genomic epidemiology studies using next generation sequencing. Front Genet. 2015;6:149.
- Li H, Durbin R. Fast and accurate short read alignment with Burrows-Wheeler transform. Bioinformatics. 2009;25(14):1754–1760.
- Richards S, Aziz N, Bale S, et al. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet Med. 2015;17(5):405–424.
- Khanna KK, Lavin MF, Jackson SP, et al. ATM, a central controller of cellular responses to DNA damage. Cell Death Differ. 2001;8(11):1052–1065.
- Verhagen MM, Last JI, Hogervorst FB, et al. Presence of ATM protein and residual kinase activity correlates with the phenotype in ataxia-telangiectasia: a genotype-phenotype study. Hum Mutat. 2012;33(3):561–571.
- Jacquemin V, Rieunier G, Jacob S, et al. Underexpression and abnormal localization of ATM products in ataxia telangiectasia patients bearing ATM missense mutations. Eur J Hum Genet. 2012;20(3):305–312.
- Méneret A, Ahmar-Beaugendre Y, Rieunier G, et al. The pleiotropic movement disorders phenotype of adult ataxia-telangiectasia. Neurology. 2014;83(12):1087–1095.
- Sasaki T, Tian H, Kukita Y, et al. ATM mutations in patients with ataxia telangiectasia screened by a hierarchical strategy. Hum Mutat. 1998;12(3):186–195.
- Buzin CH, Gatti RA, Nguyen VQ, et al. Comprehensive scanning of the ATM gene with DOVAM-S. Hum Mutat. 2003;21(2):123–131.
- Magliozzi M, Piane M, Torrente I, et al. DHPLC screening of ATM gene in Italian patients affected by ataxia-telangiectasia: fourteen novel ATM mutations. Dis Markers. 2006;22(4):257–264.
- Cummins G, Jawad T, Taylor M, et al. Myoclonic head jerks and extensor axial dystonia in the variant form of ataxia telangiectasia. Parkinsonism Relat Disord. 2013;19(12):1173–1174.
- Stankovic T, Kidd AM, Sutcliffe A, McGuire GM, et al. ATM mutations and phenotypes in ataxia-telangiectasia families in the British Isles: expression of mutant ATM and the risk of leukemia, lymphoma, and breast cancer. Am J Hum Genet. 1998;62(2):334–345.
- Mitui M, Campbell C, Coutinho G, et al. Independent mutational events are rare in the ATM gene: haplotype prescreening enhances mutation detection rate. Hum Mutat. 2003;22(1):43–50.
- Gilad S, Khosravi R, Shkedy D, et al. Predominance of null mutations in ataxia-telangiectasia. Hum Mol Genet. 1996;5(4):433–439.
- Lakin ND, Weber P, Stankovic T, et al. Analysis of the ATM protein in wild-type and ataxia-telangiectasia cells. Oncogene. 1996;13(12):2707–2716.
- Gilad S, Chessa L, Khosravi R, et al. Genotype-phenotype relationships in ataxia-telangiectasia and variants. Am J Hum Genet. 1998;62(3):551–561.
- McConville CM, Stankovic T, Byrd PJ, et al. Mutations associated with variant phenotypes in ataxia-telangiectasia. Am J Hum Genet. 1996;59(2):320–330.
- Chen Z, Ye W, Long Z, et al. Targeted next-generation sequencing revealed novel mutations in Chinese ataxia telangiectasia patients: a precision medicine perspective. PLoS One. 2015; 10(10).
- Hennekam RC, Biesecker LG. Next-generation sequencing demands next-generation phenotyping. Hum Mutat. 2012;33(5):884–886.
- Saadat M, Ansari-Lari M, Farhud D. Short Report Consanguineous marriage in Iran. Ann Hum Biol. 2004;31(2):263–269.
- Babaei M, Mitui M, Olson ER, et al. ATM haplotypes and associated mutations in Iranian patients with ataxia-telangiectasia: recurring homozygosity without a founder haplotype. Hum Genet. 2005;117(2–3):101–106.
- Tabatabaiefar MA, Alipour P, Pourahmadiyan A, et al. A novel pathogenic variant in an Iranian Ataxia telangiectasia family revealed by next-generation sequencing followed by in silico analysis. J Neurol Sci. 2017;379:212–216.